10X Genomics' GAAP loss for 9M 2021 was $39.774 million, down 3.2 times from $127.158 million in the prior year. Revenue increased 85.9% to $346.96 million from $186.627 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept